UCB SA ADR

Company Profile

UCB SA ADR had its IPO on under the ticker symbol UCBJY.

The company operates in the Healthcare sector and Biotechnology industry. UCB SA ADR has a staff strength of 8,600 employees.

Stock update

Shares of UCB SA ADR opened at $43.99 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $43.99 - $44.26, and closed at $44.25.

This is a +0.28% increase from the previous day's closing price.

A total volume of 6,700 shares were traded at the close of the day’s session.

In the last one week, shares of UCB SA ADR have slipped by -1.22%.

UCB SA ADR's Key Ratios

UCB SA ADR has a market cap of $16.79 billion, indicating a price to book ratio of 1.5518 and a price to sales ratio of 2.5382.

In the last 12-months UCB SA ADR’s revenue was $5.11 billion with a gross profit of $3.77 billion and an EBITDA of $1.14 billion. The EBITDA ratio measures UCB SA ADR's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, UCB SA ADR’s operating margin was 10.64% while its return on assets stood at 2.15% with a return of equity of 3.7%.

In Q2, UCB SA ADR’s quarterly earnings growth was a negative -22% while revenue growth was a negative 11.8%.

UCB SA ADR’s PE and PEG Ratio

Forward PE

17.5439

Trailing PE

48.6209

PEG

6.314

Its diluted EPS in the last 12-months stands at $0.91 per share while it has a forward price to earnings multiple of 17.5439 and a PEG multiple of 6.314. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into UCB SA ADR’s profitability.

UCB SA ADR stock is trading at a EV to sales ratio of 2.8057 and a EV to EBITDA ratio of 10.744. Its price to sales ratio in the trailing 12-months stood at 2.5382.

UCB SA ADR stock pays annual dividends of $1.33 per share, indicating a yield of 1.65% and a payout ratio of 123.02%.

Balance sheet and cash flow metrics

Total Assets

$15.38 billion

Total Liabilities

$2.65 billion

Operating Cash Flow

$-687000000.00

Capital Expenditure

$62 million

Dividend Payout Ratio

123.02%

UCB SA ADR ended 2024 with $15.38 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $15.38 billion while shareholder equity stood at $9.04 billion.

UCB SA ADR ended 2024 with $0 in deferred long-term liabilities, $2.65 billion in other current liabilities, 584000000.00 in common stock, $6.49 billion in retained earnings and $5.30 billion in goodwill. Its cash balance stood at $457.00 million and cash and short-term investments were $750.00 million. The company’s total short-term debt was $275,000,000 while long-term debt stood at $2.51 billion.

UCB SA ADR’s total current assets stands at $3.00 billion while long-term investments were $0 and short-term investments were $293.00 million. Its net receivables were $1.19 billion compared to accounts payable of $2.05 billion and inventory worth $912.00 million.

In 2024, UCB SA ADR's operating cash flow was $-687000000.00 while its capital expenditure stood at $62 million.

Comparatively, UCB SA ADR paid $1.23 in dividends in 2024.

Other key metrics

Current Trading Price

$44.25

52-Week High

$47.875

52-Week Low

$32.1404

Analyst Target Price

$

UCB SA ADR stock is currently trading at $44.25 per share. It touched a 52-week high of $47.875 and a 52-week low of $47.875. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $44.31 and 200-day moving average was $42.94 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0.1% are held by institutions.